Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report

Inflamm Res. 2021 Sep;70(9):931-933. doi: 10.1007/s00011-021-01476-9. Epub 2021 Jun 4.


Long-term and rare adverse effects of COVID-19 vaccines are unknown. Hence, it is important to report them to improve the safety profile of the vaccines and enhance their use worldwide. Here, we describe a case of acute visual impairment after Pfizer-BioNTech vaccine second dose.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • COVID-19 Vaccines / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Vaccination / adverse effects
  • Vision Disorders / etiology*
  • Visual Acuity / drug effects*
  • Visual Fields*


  • COVID-19 Vaccines